BERLIN/WÜRZBURG (dpa-AFX) - Pentixapharm, which previously belonged to Eckert & Ziegler, has set the price for its shares in the lower half of the announced range. All 3.9 million offer shares from a capital increase have been placed at a price of 5.10 euros each, the company announced in Berlin on Tuesday evening. Last week, Pentixapharm had set the price range at 4.70 euros to 6.00 euros. Overall, the company has a market capitalization of around 126.5 million euros.

The company expects the sale of the new shares to generate gross proceeds of just under 20 million euros. After completion, the free float is expected to be 61.6 percent. Eckert & Ziegler, which is listed on the SDax, remains the largest single shareholder. Trading in the existing shares and the spin-off securities of Pentixapharm Holding is scheduled to begin on October 3. The shares from the offer are expected to be included one week later./ngu/he